AmGen Announces Cyberattack and Data Breach Involving Patient Data
Amgen, a major biopharmaceutical company specializing in cancer, blood, and cardiovascular treatments, has disclosed a cyberattack that resulted in a breach of patient data. The company has not yet publicly detailed the scope of the breach or the specific types of information compromised.
Who should care: Cybersecurity · Privacy officers · Administrators · Healthcare professionals · Compliance